Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Ossur Power -polven biomekaaninen arviointi henkilöillä, joilla on transfemoraalinen amputaatio (OPKTFA)

torstai 17. syyskuuta 2026 päivittänyt: VA Office of Research and Development

Parantavatko transfemoraaliset proteesit polviproteesin taivutuksella ja pidennyksellä liikkuvuutta? Ossur Power Kneen biomekaaninen arviointi

Microprocessor-controlled knees (MPKs) do not typically utilize motors to power joint rotation, but they automatically adjust resistance or damping in the joint to improve swing- and/or stance-phase control as appropriate for the prosthesis user during gait. The Ossur Power Knee is the only commercially-available MPK that uses a motor to provide active power generation during walking and other activities. The purpose of this proposed investigation is to perform and compare biomechanical evaluations of the Power Knee and Ossur Rheo XC, a passive MPK, during walking and other activities by prosthesis users. Furthermore, mobility between male and female subjects will be compared to determine if there are differences in prosthetic knee usage on the basis of sex.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

The anatomical knee is a complex, polycentric joint characterized by a large range of motion in the sagittal plane and limited mobility in the coronal and transverse planes. The sagittal plane motion is used for progression in stance phase, and limb clearance and advancement in swing. Limb prostheses are intended to restore function and cosmesis in persons with limb loss. The complexity and function of prosthetic components have advanced significantly as technology has improved, but a state-of-the-art artificial limb is still a relatively poor substitute for an anatomical one. Microprocessor-controlled knees (MPKs) do not typically utilize motors to power joint rotation, but they automatically adjust resistance or damping in the joint to improve swing- and/or stance-phase control as appropriate for the user during gait. The Ossur Power Knee, which was first introduced in 2006, is the only MPK that uses a motor to provide active power generation during walking and other activities involving knee flexion and extension. Last year, Ossur released the 3rd generation of its Power Knee and appears to have addressed many of the previous shortcomings in terms of reduced weight, less noise, lower cost and longer battery life. Therefore, the newest version of the Power Knee warrants a fresh evaluation since it is, in essence, substantially different in design and function from previous models.

The purpose of this proposed investigation is to perform biomechanical evaluations of the new Ossur Power Knee during walking and other activities by transfemoral prosthesis users. Using a cross-over experimental design, approximately 20 unilateral, transfemoral amputee subjects (10 men and 10 women) will be evaluated in the Jesse Brown VAMC Motion Analysis Research Laboratory (MARL) while wearing the Ossur Power Knee and Ossur Rheo XC, which is a passive MPK device. Furthermore, the Ossur Power Knee may offer distinct advantages to female prosthesis users, so mobility will be compared between men and women to determine if differences exist on the basis of sex. The specific aims and hypotheses of this project are:

Aim 1: To compare the effects of the Ossur Power Knee and Ossur Rheo XC on the gait of unilateral, transfemoral prosthesis users during level walking. Kinematic and kinetic data will be collected as subjects walk in the MARL. Hypothesis--the active knee flexion and extension provided by the Ossur Power Knee will (1) improve walking performance, and (2) reduce metabolic energy cost during ambulation.

Aim 2: To compare the effects of the Ossur Power Knee and Ossur Rheo XC on stairs, slopes and during sit-to-stand/stand-to-sit activities of unilateral, transfemoral prosthesis users. Kinematic data will be collected as subjects perform these activities. Hypothesis--subjects will have improved performance when using the Ossur Power Knee.

Aim 3: To analyze and compare gender specific data between subjects using the Ossur Power Knee and the Ossur Rheo XC. Hypothesis--male and female subjects will demonstrate substantially different abilities to use the two knee components, indicating that gender specific components should be further investigated and developed. Research focusing on the unique prosthetic needs of women Veterans is currently a special emphasis area of the VA RR&D Service.

Subjects will also be administered questionnaires and provided at-home diaries to document their perceptions of comfort, exertion and stability while using the different prosthetic knee units.

The repeated-measures, cross-over protocol design enables each subject to serve as their own control, and it will be determined whether statistically significant changes occur in their performance measures. A two-way mixed-methods ANOVA will be used to assess the main and interaction effects of sex (male, female) and knee type (Ossur Power Knee, Rheo XC). As a conservative approach, a Bonferroni correction will be used to account for the family-wise Type I error rate because multiple outcomes will be used to address each hypothesis.

Increased understanding about how the Ossur Power Knee affects the abilities of transfemoral prosthesis users will facilitate appropriate component selection by prosthetists and ultimately improve quality of life for prosthesis users.

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

20

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

Tutki yhteystietojen varmuuskopiointi

Opiskelupaikat

    • Illinois
      • Chicago, Illinois, Yhdysvallat, 60612
        • Rekrytointi
        • Jesse Brown VA Medical Center, Chicago, IL
        • Ottaa yhteyttä:
        • Päätutkija:
          • Steven A Gard, PhD
        • Ottaa yhteyttä:

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

45 vuotta - 75 vuotta (Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • Unilateral, transfemoral amputation (any etiology)
  • Residual limb length classified as standard (i.e., medium) to long
  • Prosthesis user for at least 1 year prior to enrolling in the study
  • K3 or K4 level ambulator
  • Good sensation on their residual limb(s) (upon routine clinical examination)
  • Good skin integrity upon visual inspection
  • Does not require the use of assistive devices to walk for short distances
  • Not currently taking medications that are known to affect balance or gait
  • Presents with good socket fit based upon a standard assessment by the study prosthetist

Exclusion Criteria:

  • Bilateral amputations
  • Individuals with a knee disarticulation

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Hoito
  • Jako: Satunnaistettu
  • Inventiomalli: Crossover-tehtävä
  • Naamiointi: Ei mitään (avoin tarra)

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Ossur Power Knee

Subjects will be fitted with the Ossur Power Knee, which has powered flexion and extension.

Subjects will be fitted and trained on the Ossur Power Knee. An accommodation of 1 month will be provided prior to evaluation with the knee joint.

Muut nimet:
  • Ossur Power Knee
Active Comparator: Ossur Rheo XC Knee

Subjects will be fitted with the Ossur Rheo XC Knee, which is a conventional microprocessor-controlled prosthetic knee joint that modulates the amount of damping during flexion and extension.

Subjects will be fitted and trained on the Ossur Rheo XC Knee. An accommodation of 1 month will be provided prior to evaluation with the knee joint.

Muut nimet:
  • Ossur Rheo

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Walking speed
Aikaikkuna: To be measured after the 1-month accommodation period of wearing each prosthetic knee component

Walking speed will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Metabolic energy cost
Aikaikkuna: To be measured after the 1-month accommodation period of wearing each prosthetic knee component

The metabolic energy rate will be measured as subjects walk at their freely selected speed on a level treadmill, which will be converted to metabolic energy cost (energy expended per unit distance).

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Sit-to-stand/stand-to-sit symmetry
Aikaikkuna: To be measured after the 1-month accommodation period of wearing each prosthetic knee component

Knee kinematics and load distribution between the sound and prosthetic sides will be measured as participants stand up and sit down in a chair.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Step length
Aikaikkuna: To be measured after the 1-month accommodation period of wearing each prosthetic knee component

The step lengths of the sound and prosthetic sides will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Toe clearance during swing phase
Aikaikkuna: To be measured after the 1-month accommodation period of wearing each prosthetic knee component

Toe clearance during swing phase on the prosthetic side will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Sound leg loading rate
Aikaikkuna: To be measured after the 1-month accommodation period of wearing each prosthetic knee component

The sound leg loading rate during walking will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Kinematics of pelvic motion
Aikaikkuna: To be measured after the 1-month accommodation period of wearing each prosthetic knee component

Pelvic tilt, rotation and obliquity will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Tutkijat

  • Päätutkija: Steven A Gard, PhD, Jesse Brown VA Medical Center, Chicago, IL

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Maanantai 1. huhtikuuta 2024

Ensisijainen valmistuminen (Arvioitu)

Sunnuntai 31. tammikuuta 2027

Opintojen valmistuminen (Arvioitu)

Keskiviikko 31. maaliskuuta 2027

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Torstai 11. tammikuuta 2024

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Torstai 11. tammikuuta 2024

Ensimmäinen Lähetetty (Todellinen)

Tiistai 23. tammikuuta 2024

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Tiistai 22. syyskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Torstai 17. syyskuuta 2026

Viimeksi vahvistettu

Tiistai 1. syyskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muut tutkimustunnusnumerot

  • A4541-R
  • RX004541-01A2 (Muu apuraha/rahoitusnumero: VA RRD)
  • 5I01RX004541-02 (Yhdysvaltain NIH-apuraha/sopimus)

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

IPD-suunnitelman kuvaus

A Limited Dataset (LDS) will be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset. Results from this study will be freely disseminated via presentations at professional conferences and publications in scientific journals. Additionally, data acquired for this project will be shared with those investigators who make a formal request to the PI and can demonstrate a legitimate and justifiable cause for utilization of such data. All requests for these data will be discussed with the VA scientific program manager.

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Yhdysvalloissa valmistettu ja sieltä viety tuote

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa